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Abstract The goal of this study
was to explore the relationship
between indicators of sympa-
thoneural, sympathomedullar and
hypothalamic-pituitary-adrenocor-
tical (HPA) activity and stress-
induced head and shoulder–neck
pain in patients with migraine or
tension-type headache (TTH). We
measured noradrenaline, adrena-
line and cortisol levels before and
after low-grade cognitive stress in
21 migraineurs, 16 TTH patients
and 34 controls. The stressor lasted
for 60 min and was followed by 30
min of relaxation. Migraine
patients had lower noradrenaline
levels in blood platelets compared
to controls. Pain responses corre-
lated negatively with noradrenaline
levels, and pain recovery correlat-
ed negatively with the cortisol
change in migraineurs. TTH
patients maintained cortisol secre-
tion during the cognitive stress as
opposed to the normal circadian
decrease seen in controls and
migraineurs. There may therefore
be abnormal activation of the HPA
axis in patients with TTH when
coping with mental stress, but no
association was found between
pain and cortisol. A relationship
between HPA activity and stress in
TTH patients has to our knowledge
not been reported before. In
migraine, on the other hand, both
sympathoneural activation and
HPA activation seem to be linked
to stress-induced muscle pain and
recovery from pain respectively.
The present study suggests that
migraineurs and TTH patients cope
differently with low-grade cogni-
tive stress. 
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Introduction
Stress may trigger headache in both migraine and tension-
type headache (TTH) patients [1–4]. An abnormal and pro-
longed stress response has been hypothesised to cause chron-
ic pain [5, 6], and pain processing seems to be abnormal in
TTH [7–9] and in migraine [10, 11]. Stress increases sympa-
thoneural and sympathomedullar sympathetic nervous sys-
tem activity and it may also activate the hypothalamic-pitu-
itary-adrenocortical (HPA) axis, but it is not known if this
activation is correlated to pain and headache development
during a stressful task. Noradrenaline in blood plasma is con-
sidered an indicator of sympathoneural activity, as most of
the circulating NA is released from sympathetic nerve end-
ings, particularly in muscle [12]. Plasma adrenaline is
released mainly by the adrenal medulla and reflects part of
the subject’s sympathomedullar activity. The primary mark-
er for HPA activity in humans is cortisol, having complex
and diverse effects throughout the body [13, 14].
Sympathetic activity has been measured by means of bio-
chemical markers in both migraineurs [15–18] and TTH
patients [16, 19]. Some of these studies investigated biochem-
ical effects of short-lasting stress from stressors such as cold
pressor tests, tilt tests, mental arithmetic tests etc. It may be
argued that these short-lasting stressors are of limited rele-
vance with respect to long-lasting, low-grade stressors often
reported to induce headaches in daily life. In the present model
[20–22], we sought to create a low-grade cognitive stressor in
order to simulate real-life stress in an office environment.
Elevated plasma cortisol has been reported in migraine
[23, 24] and a trend towards higher cortisol has been report-
ed in TTH [23]. The cortisol response to low-grade cognitive
stress has to our knowledge not been studied in headache
patients previously. In this paper, we report cortisol, nora-
drenaline (NA) and adrenaline changes in response to stress
in patients and controls, and consider potential correlations
between the biochemical variables and pain responses and
pain recovery. We have also considered the possibility that
HPA activation (cortisol secretion) might be correlated to
cardiovascular reactivity in migraine and TTH.
Materials and methods
Subjects
The background data of all the subjects that entered the physiolog-
ical study have been published previously [20]. Background data on
subjects with biochemical data are displayed in Table 1 (due to
technical problems, 10 controls, one migraineur and two TTH
patients, had no biochemical data). There were no differences
between the patients and controls for these data. Patients were diag-
nosed according to the International Headache Society classifica-
tion of headache from 1988 [25]. Control subjects did not suffer
from headache or musculoskeletal pain for more than one day per
month. Exclusion criteria were: neoplastic disease, hypertension,
infectious disease, metabolic, endocrine or neuromuscular diseases,
significant psychiatric disorders, connective tissue disorder, ten-
dinitis, recent significant accident or injury, pregnancy, daily med-
ication with neuroleptics, antiepileptics, Ca2+-blockers, β-blockers,
antidepressants and significant associated diseases affecting either
the heart, lungs, cerebrovascular system, central or peripheral ner-
vous system. Migraineurs with TTH more than 7 days per month
were also excluded. The migraine patients were recruited from our
tertiary headache facility. Patients referred to such a facility often
have more severe headaches or more complex symptoms (such as
auras), and among these patients the proportion of women is high-
er than would be expected from the gender ratio of migraineurs in
the general population. The project was approved by the Regional
Ethics Committee and performed in accordance with the 1964
Declaration of Helsinki. All participants gave written informed con-
sent. The participants were provided with written information con-
cerning the aim of the study prior to the day of the stress test. The
aim of studying pain and headache was mentioned, but the infor-
mation focused on the practical details of the procedure.
Questionnaire and interview
Patients arrived at our facility around 8 a.m. and underwent a struc-
tured interview concerning headaches and musculoskeletal com-
plaints (distribution, severity and duration) prior to the stress test.
The interview was conducted in a calm and relaxed manner with the
subject sitting comfortably, and lasted around 30 min. One of the
interview questions was: “Please state the level of general tension
you have felt during the last 2–3 months”, and the response was
scored on a visual analogue scale (VAS) with endpoints: not
tense–very tense. Participants also kept a headache diary for 7 days
before and after the stress test. Twelve of 21 migraineurs reported a
migraine attack within two days before the stress test, while 11
patients reported an attack within two days after the stress test. The
neuroticism index of the Eyseneck Personality Questionnaire
(EPQ-N) scores was also calculated from the questionnaire (Table
1). Two questions in this questionnaire dealt with symptoms of
depression, and there were no group differences in the answers to
these questions. At the end of the interview, the first blood sample
was drawn by venipuncture.
Procedure
The stress test procedure is described in detail in another paper [20],
and only a short summary will be given here. The subjects per-
formed a two-choice reaction-time test presented on a PC monitor for
60 min. They were instructed to perform the test as quickly and cor-
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rectly as possible, and were provided with feedback on their perfor-
mance throughout the test. They were also informed that they would
be monitored through a video camera. The subjects were acclimatised
to the laboratory environment for 30 min, during which the procedure
was explained and the recording electrodes were attached to the
patient. The technician told the subject to relax and then left the room.
The recording started with 5 min uninstructed rest (UIR), followed by
5 min active, instructed rest with visual EMG feedback (FB). During
the FB period the technician instructed the subject in a calm, quiet
manner on how to relax the muscles more efficiently based on the
patient’s own EMG data shown on the computer screen. The cogni-
tive task was then performed for 1 h (800–1500 trials), followed by
30 min recording during rest (recovery period). The subjects were
asked to relax while seated and to move as little as possible during the
recovery period. After the UIR and FB periods, at 10-min intervals
during the cognitive task, and at 10-min intervals during the recovery
period, the subjects were asked to mark on a VAS scale their level of
pain (no pain–worst bearable pain). Pain was reported bilaterally for
the forehead, temples, neck and shoulder (upper trapezius area). No
patient had to be excluded because of headache attacks during the
test. EMG was recorded bilaterally at the forehead, temples, neck and
upper trapezius. Systolic blood pressure (BPsys), diastolic blood pres-
sure (BPdia), heart rate (HR) and finger blood flow (BF) were contin-
uously recorded during the test, and mean values calculated for the
UIR and FB period, and for each 10-min interval throughout the
stress test and recovery period.
Venous blood was sampled again immediately after the stress-
ful task. The two blood samples were therefore taken with an inter-
val of 2–3 h. More frequent sampling by a cannula was considered
but rejected because we anticipated that it would interfere with
pain, tension, EMG and cardiovascular measurements. Patients
were able to relax before the first blood sample, and both the nurse
and the technician involved in the stress test were instructed to act
in a quiet, calm manner at all times. The stress test was performed
in a quiet room with no distractions. So while we were unable to
control for stressful events that the subjects might have experienced
prior to arriving at our facility, we were careful to avoid unneces-
sary stressful situations after arrival.
Biochemical analyses
Blood was collected into EDTA vacutainers and immediately
placed in ice water or into vacutainers without an anti-coagulant.
Non-coagulated blood was centrifuged for 10 min at 300 g (at a
temperature of 4°C) to obtain platelet-rich plasma (PRP). After
withdrawing an adequate sample of PRP for catecholamine analysis
and platelet counting, samples were centrifuged again for 10 min at
3000 g (4°C) to obtain platelet-poor plasma (PPP). Serum was col-
lected after 30 min coagulation, by centrifugation at 1500 g, 10 min,
at room temperature. All samples were stored at –80°C prior to
analysis. Plasma catecholamines were extracted by adsorption to
aluminium oxide [26] and analysed by HPLC (Merck Hitachi
LaChrom system, Darmstadt, Germany) with electrochemical
detection. Catecholamines were separated on a LiChroCART 250-4
column containing LiChrospher 100 RP-18 (5 μm) (Merck,
Darmstadt, Germany), using a sodium acetate buffer (pH 4.8) and
methanol (8.5 vol%) as eluents [27]. External standards were used
for calculation of sample catecholamine concentrations. Cortisol
concentrations in serum samples were determined using a compet-
itive enzyme immunoassay kit (R&D Systems, Abingdon, UK).
Serum samples were diluted 8-fold, processed and analysed by
absorbance reading (Titertek Multiscan, Titertek, AL, USA) at 405
nm, according to the manufacturer’s procedure. Catecholamine
Table 1 Background data on subjects included in the study
Diagnostic group Controls (n=34) Migraine (n=21) Tension-type headache (n=16)
Gender ratio (F:M) 30:4 19:2 7:9
Mean age (range) 41.0 (19–61) 41.2 (21–60) 35.6 (19–52)
Mean number of years with headache (range) – 20.1 (7–37) 8.7 (0–32)
Number of subjects with chronic headache (%) – 4 (19.0) 12 (75.0)
Mean duration (h) of headache attacks (range)a – 30 (1–72) –
Number of subjects with aura (%) – 12 (57.1) –
Mean general tension (VAS) (range) 29.7 (0–84) 36.0 (1–87) 26.5 (0–65)
Mean EPQ-N score (SD) 7.4 (4.2) 9.0 (4.0) 8.25 (4.9)
Number of subjects who smoke (%) 10 (29.4) 6 (28.6) 2 (12.5)
Body mass index (SD) 25.1 (3.6) 24.0 (3.3) 25.1 (4.5)
Days since last menstruation (SD)b 17.0 (11.9) 19.2 (14.8) 17.1 (17.2)
aOne migraine patient had some attacks of short duration
bFourteen women (7 controls, 6 migraineurs and 1 TTH patient) had started menopause. Three women had for unknown reasons reported more
than 35 days since their last menstruation (1 control, 1 migraineur and 1 TTH patient)
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analyses were done for 27 controls, 19 migraineurs and 14 TTH
patients. Cortisol analyses were done for 24 controls, 17
migraineurs and 13 TTH patients. Adrenaline levels in PRP sug-
gested degradation, probably by MAO-B [28], and are not shown.
Data analyses
Levels of plasma NA and adrenaline, platelet NA and cortisol, as
well as plasma platelet levels (not shown) were calculated before
and after the stress test. Biochemical changes were calculated from
the difference in concentration after the test compared to levels
before the test.
The pain variables used in the statistical analyses were pain
response and pain recovery. The pain response was defined as the
highest pain response (max pain at t10–60min–pain at t0min) among the 8
location- and side-specific responses. The minimal pain during recov-
ery was used first to calculate 8 location- and side-specific pain recov-
eries (minimal pain at t75–95min–pain at t0min). Thereafter, the highest
among these 8 location- and side-specific pain recoveries was defined
as pain recovery. Mean cardiovascular responses (mean level
t(0–10min)–(50–60min)–baseline) and mean cardiovascular recovery (mean
level t(65–75min)–(85–95min)–baseline) were used in analyses involving
BPsys, BPdia or HR.
Based on the goal of the study, the following variables were
used in correlation analyses: (a) biochemical changes vs. pain
response and recovery, (b) pre-test biochemical levels vs. pain
response (c) post-test biochemical levels vs. pain recovery, (d)
post-test biochemical levels vs. pain response, (e) cortisol change
vs. mean cardiovascular responses, (f) pre-test cortisol level vs.
mean cardiovascular responses and (g) post-test cortisol level vs.
mean cardiovascular recovery. Correlations between cate-
cholamine changes and cardiovascular responses were not includ-
ed in the study aim and hence not reported.
A few subjects had partly missing data due to technical difficul-
ties: two controls and two migraineurs had corrupted BP and HR
data during the test and recovery period. One control had missing
pain data at t95min, while one patient with TTH had corrupted BP,
HR, BF and pain data during the recovery period.
Statistics
Kolmogorov-Smirnov’s test was used to confirm that all (ln-trans-
formed) biochemical data were close to a Gaussian distribution.
Differences in biochemical levels pre- and post-test were analysed
by paired Student’s t-test. Analysis of variance (ANOVA) with
repeated measures was used for intergroup comparisons of bio-
chemical changes in response to stress (time×group interactions).
One-way ANOVA with post-hoc Tukey’s test was used for inter-
group comparisons of pre-test variables. For pain data the non-para-
metric Spearman’s rank order ρ was used for correlation analysis.
Pain responses were power-transformed by a factor x0.5 for a closer
Gaussian distribution when used as a covariate in ANOVA analyses.
A two-tailed significance level of <0.05 was considered significant.
P-values within a range of 0.05–0.10 were considered as trends.
Results
Pre-test, post-test and response means are shown in Table 2.
Pre- and post-test levels of plasma NA and adrenaline, and
platelet NA and cortisol are shown in Figure 1.
Biochemical changes in response to stress
We found no significant differences in pre-test biochemical
levels between any of the diagnostic groups. Significant dif-
ferences in pre- vs. post-test levels were found for cortisol in
controls (p″ 0.005) and migraineurs (p=0.008) but not in
TTH (p=0.93). A trend (post-hoc Tukey’s, C vs. M, p=0.07)
towards lower pre-test platelet NA was found in migraine
patients compared to controls (Table 2). Catecholamine
mean levels changed little, but tended to be lower after the
test in controls and migraineurs, and remain stable or be
higher after the test in TTH.
To compare biochemical levels and biochemical changes
between the three groups, two-group ANOVA analyses were
done (Table 3). Platelet NA levels were found to be signifi-
cantly lower in migraineurs compared to controls, and plasma
NA levels in migraineurs tended to be lower than in controls.
TTH patients had a significantly different cortisol change (no
decrease with time) compared to controls or migraineurs.
Correlations between pain and biochemical variables
Pain development is shown in Figure 2, and Table 4 shows data
on the pain variables used in the correlation analyses.
Migraineurs had negative correlations between pre-test platelet
NA and pain responses (rs=–0.55, p=0.02), and between post-
test plasma NA and pain responses (rs=–0.58, p=0.009).
Migraineurs also showed a negative correlation between pain
recovery and the cortisol response (rs=–0.52, p=0.03). TTH
patients had a negative correlation between pain recovery and
the plasma NA response (rs=–0.64, p=0.01). There were no cor-
relations between biochemical variables and pain in controls.
Correlations between cardiovascular variables and cortisol
Figure 3 shows the cardiovascular development during and
after the stress test, and Table 4 shows the cardiovascular
variables used in the correlation analyses. In controls, the
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cortisol change was positively correlated to the BPsys
responses (rs=0.55, p=0.01). The pre-test cortisol was also
correlated positively with the mean BF responses in controls
(rs=0.44, p=0.03). In TTH patients pre-test cortisol correlat-
ed negatively with the HR mean response (rs=–0.57, p=0.04),
and there was a trend towards a positive correlation between
the cortisol change and the mean HR response (rs=0.49,
p=0.09). In migraineurs pre-test cortisol correlated positive-
ly with the mean BPsys response (rs=0.52, p=0.048).
Discussion
There is conflicting evidence on the basal levels of cate-
cholamines in migraineurs, as both higher, equal and lower
levels compared to controls have been found [17, 18, 29–31].
For patients with TTH, previous studies have demonstrated
lower levels of catecholamines compared to controls [16, 19,
32]. Mean basal levels of catecholamines tended to be lower
for both the migraineurs and TTH patients compared to
healthy controls in our study, but the differences did not
reach statistical significance.
There were no significant differences between pre- and
post-test catecholamine levels in the three subject groups.
Similarly, no rise in NA and adrenaline has been found after
mental arithmetic tests in healthy subjects [33]. However,
there were marked heart rate and BP rises during the stress in
our study, indicating that sympathetic autonomic activation
does occur. This may suggest that NA and adrenaline levels
in the forearm are less sensitive indicators of sympathoneur-
al and sympathomedullary activation to low-grade cognitive
stress than physiological variables.
We have previously reported higher pain responses during
stress in migraineurs compared to controls [20]. The present
paper shows that platelet and plasma NA levels were lower in
migraineurs than in controls, suggesting that migraineurs may
have noradrenergic hypofunction, potentially related to the
Fig. 1 Pre- and post-test mean values (SEM) of noradrenaline in plasma, noradrenaline in platelets, adrenaline in plasma, and cortisol in




















































































mechanism for stress-induced pain. The inverse relationship
between pain responses and both pre-test platelet NA and post-
test plasma NA indicates that stress-induced pain increases at
lower levels of NA. Altered central noradrenergic activity has
previously been indicated in patients with chronic migraine, as
evidenced by an inverse correlation between clonidine-induced
β-endorphine secretion and pre-test pain [34].
TTH patients have delayed pain recovery after stress
compared to controls [20]. In the present study, TTH patients
showed a negative correlation between pain recovery and the
plasma NA response. Hence, it seems that low sympa-
thoneural activation is associated with prolonged pain during
recovery in TTH-patients. A blunted acute BP and HR
response to stress onset is compatible with low sympa-
thoneural activation in TTH.
Cortisol levels in TTH patients did not change signifi-
cantly during the test, in contrast to the reductions in controls
and migraineurs. During a normal circadian rhythm cortisol
levels are high in the morning and decrease throughout the
day [35]. The test subjects arrived at our facility between
08:00 and 08:45 and had their pre-test blood sample taken 30
min later. As the post-test samples were not taken for another
2.5–3 h, a decrease in cortisol levels could be expected. As
such a decrease was found in both controls and migraineurs,
the test did not appear to affect the normal rhythm. However,
Table 2 Pre- and post-test levels and response mean values (SD) for noradrenaline in plasma, noradrenaline in platelets, adrenaline in plas-
ma, and cortisol in controls, migraineurs and TTH patients
Controls (n=34)* Migraine (n=21)* Tension-type headache (n=16)*
Noradrenaline  Pre-test 1.95 (1.36) 1.42 (0.56) 1.41 (0.66)
in plasma (nM) Post-test 1.78 (1.26) 1.30 (0.51) 1.32 (0.53)
–0.21 (0.51) –0.12 (0.47) –0.09 (0.31)
Noradrenaline  Pre-test 0.40 (0.30) 0.31 (0.16) 0.31 (0.18)
in platelets Post-test 0.33 (0.43) 0.26 (0.15) 0.38 (0.16)
(ng/109 platelets) –0.07 (0.47) –0.05 (0.21) 0.07 (0.25)
Adrenaline  Pre-test 2.45 (0.94) 2.21 (1.02) 1.77 (0.55)
in plasma (nM) Post-test 2.21 (0.69) 2.00 (1.17) 1.93 (1.06)
–0.26 (0.84) –0.17 (0.70) 0.16 (0.85)
Cortisol  Pre-test 18.9 (6.6) 18.1 (5.1) 17.9 (6.58)
in serum (nM) Post-test 11.1 (4.3) 13.4 (5.5) 18.1 (7.8)
–7.84 (7.76) –4.75 (7.68) 0.22 (6.44)
Response = difference between post-test and pre-test levels
*N shown for patients with either catecholamine or cortisol analysis (or both). Specific n for each analysis: catecholamines: C=27, M=18,
TTH=14; cortisol: C=24, M=17, TTH=13
Trend towards difference between patients and controls (ANOVA w/post-hoc Tukey’s test, 0,05 p<0.1)
Significant difference in intragroup pre- and post-tests levels (paires Student’s t-test, p<0.05)
Fig. 2 Pain development throughout the stress test and recovery
period. Values are given as group means (SEM), where maximal
reported pain (from the trapezius, splenius, temporalis and frontal-
is areas, irrespective of side) for each subject was used in the cal-
culations. 0–60 min, duration of the cognitive stress test. 65–95
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the lack of cortisol change during the test in TTH patients sug-
gests either that they have increased HPA activity during stress
and thus maintain their cortisol levels despite the natural cir-
cadian decrease, or perhaps that TTH patients, like depressed
patients [36], have a blunted circadian cortisol rhythm.
TTH patients had delayed HR and BP responses and pro-
longed vasoconstriction, presumably reflecting a dysfunc-
tional sympathetic response. However, as blood was sam-
pled only twice, it was impossible to detect any biochemical
changes during the early phase of the stress period. Leone
and co-workers reported a trend towards higher cortisol
baseline values in migraineurs and TTH patients compared
to controls [23], while Peres and co-workers found higher
24-h cortisol concentrations in chronic migraine compared
to a control group [24].
The relationship between cortisol changes and pain was
different in TTH and migraine. In migraineurs a higher cor-
tisol change seemed to “protect” against delayed pain recov-
ery, suggested by the inverse relationship between the corti-
sol response and pain recovery. However, there was no sim-
ilar association in TTH patients. The (relatively) increased
cortisol excretion during stress in TTH did not affect stress-
induced pain responses or pain recovery.
Lack of HR adaptation was seen in TTH patients during
stress in a previous study (submitted results), with a small
initial increase in HR followed by a slowly increasing
response for the remainder of the stress test. This was in
contrast to controls and migraineurs, who had a larger initial
Fig. 3 Development of systolic BP, diastolic BP, heart rate and finger blood flow throughout the stress test and recovery period. Values are
given as group means (SEM). UIR, uninstructed rest period (baseline EMG). FB, EMG feedback aided rest period. 0–60 min, duration of
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increase followed by a decline in HR throughout the test. In
the present paper we show that cortisol levels were main-
tained during the stress test in TTH patients. Cortisol can
enhance vascular reactivity, for instance by increasing the
effects of circulating NA and adrenaline, and it is therefore
likely to affect HR development during the test. There was
a trend towards a positive correlation between the cortisol
response and the mean HR response, which is in accordance
with the predicted effect of cortisol secretion.
There are studies indicating that the way subjects perceive
and cope with a stressor influences HPA activity. A meta-
analysis showed that performance tasks perceived as social-
evaluative, especially those with uncontrollable factors, pro-
voked a greater release of cortisol than tasks without such fac-
tors [37]. Our stress model involved such social-evaluative
aspects, as the subjects knew they were being monitored
through a video camera. There were also uncontrollable fac-
tors, as the patients were instructed to sit still and work as fast
and correctly as possible, with no way to take breaks or move
to relieve themselves from pain or stress. Hence, the fact that
TTH patients in our study maintained their cortisol levels dur-
ing the stressful task suggests that they cope differently with
the stressor than controls or migraineurs.
The methodology for sampling cortisol from our sub-
jects may have been sub-optimal. Dickerson and Kemeny
[37] suggest that cortisol assessments 21–40 min from stres-
sor onset should be obtained in order to detect the peaks in
cortisol levels, while our results were sampled 60 min after
Table 4 Physiological/pain responses and recovery for controls, migraineurs and TTH patients
Variable Controls (n=34) Migraine (n=21) Tension-type headache (n=16)
Systolic BP (mmHg) Mean response 12.1 (8.1) 13.4 (8.5) 13.5 (10.0)
Mean recovery 11.0 (10.0) 7.7 (13.0) 10.1 (12.9)
Diastolic BP (mmHg) Mean response 8.7 (5.2) 8.7 (7.3) 8.1 (6.5)
Mean recovery 8.7 (6.1) 8.1 (6.8) 7.2 (7.5)
Heart rate (bpm) Mean response 2.2 (3.9) 3.2 (4.7) 1.5 (2.8)
Mean recovery –1.5 (3.7) –0.9 (3.9) –2.5 (4.1)
Blood flow (AU) Mean response –39.9 (66.1) –39.9 (74.2) –34.1 (46.0)
Mean recovery –73.1 (97.0) –31.2 (95.7) –80.3 (69.9)
Pain (VAS) Max. response 15.3 (16.0) 22.6 (18.6) 36.1 (26.8)
Max. recovery 2.9 (6.7) 4.4 (6.4) 13.6 (16.5)
Arbitrary units. Only subjects with valid biochemical data
Table 3 Test statistics for repeated measures two-group ANOVA analyses
Time×group interaction* Group effect*
Noradrenaline in plasma C vs. M F(42,1)=0.002 p=0.96 F(42,1)=3.46 p=0.07
C vs. TTH F(37,1)=0.14 p=0.72 F(37,1)=0.76 p=0.39
M vs. TTH F(30,1)=0.09 p=0.77 F(30,1)=0.53 p=0.47
Noradrenaline in platelets C vs. M F(39,1)=0.02 p=0.90 F(39,1)=8.68 p=0.005
C vs. TTH F(36,1)=0.75 p=0.39 F(36,1)=0.006 p=0.94
M vs. TTH F(28,1)=0.12 p=0.73 F(28,1)=2.29 p=0.14
Adrenaline in plasma C vs. M F(39,1)=2.79 p=0.6 F(39,1)=1.11 p=0.30
C vs. TTH F(35,1)=0.95 p=0.34 F(35,1)=2.4 p=0.13
M vs. TTH F(29,1)=2.23 p=0.15 F(29,1)=0.06 p=0.81
Cortisol in serum C vs. M F(38,1)=0.95 p=0.34 F(38,1)=0.76 p=0.39
C vs. TTH F(34,1)=12,6 p=0.001 F(34,1)=4.86 p=0.03
M vs. TTH F(27,1)=5.09 p=0.032 F(27,1)=0.93 p=0.34
*Time×group interactions reflect differences in biochemical development (changes pre- to post-test), while group effects reflect overall differ-
ences in biochemical levels between the groups
Significant difference between subject groups, p<0.05
Trend towards difference between subject groups, 0.05≤p<0.1
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the onset of the stressor. Additionally, some aspects of the
cortisol response to stress may have been hidden as the sam-
ples were taken during the morning hours when the cortisol
level was decreasing due to the circadian rhythm. However,
as the test was performed in the morning for all subjects, we
find it likely that the reported group differences between
TTH patients and controls and migraineurs are real.
It is a weakness of our study that the sample size was
limited and gender distribution in the three groups was
uneven. We had some problems with recruiting enough
patients and controls, resulting in groups that were smaller
than intended. Technical difficulties with some of the blood
samples decreased the sample size even more. The low
group size and uneven gender distribution made gender-spe-
cific statistical analyses less meaningful due to a low sam-
ple power, and we have therefore based our analyses on
groups consisting of both men and women. When investi-
gating differences in biochemical changes in men and
women irrespective of diagnosis (48 women vs. 11 men for
catecholamines, 42 women vs. 12 men for cortisol), no gen-
der differences could be found (results not shown).
Reproductive steroid levels may also influence the stress
response [38], and future work in this area is warranted.
However, as female reproductive steroid levels change
throughout the menstrual cycle, a large number of women
would need to be recruited.
In conclusion, the two patient groups responded differently
to the stressor, both compared to each other and to controls. For
migraineurs the NA levels were lower than for controls, and
negatively correlated to the pain response, which may indicate
that the sympathoneural responses to stress protect against
stress-induced pain. TTH patients on the other hand seem to
have a derangement of the HPA axis. Increased HPA axis reac-
tion to low-grade evaluative and uncontrollable cognitive stress
in TTH is plausible, but the association between HPA activa-
tion and acute pain is uncertain. Such a relationship between
HPA activity and stress in TTH patients has to our knowledge
not been reported before. A detailed study of cortisol secretion
and regulation in TTH is warranted, and more generally, further
studies on the relation between headache, stress and the differ-
ent biochemical and physiological stress markers may give
important insights into headache pathogenesis.
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